Tag: OTC:KHRNF

July 17, 2019

Khiron Obtains Final Approval to Commercialize CBD Production and Receives Approval for an additional 17 Cannabis Strains from Colombian Agricultural Institute

Khiron Life Sciences Corp. ("Khiron" or the "Company") (TSXV:KHRN, OTCQB:KHRNF, Frankfurt:A2JMZC) a vertically integrated cannabis leader with core operations in Latin...
July 16, 2019

Khiron Featured in the Motley Fool

Khiron Life Sciences Corp. (TSXV:KHRN,OTCQB:KHRNF,FWB:A2JMZC) has been featured in a sponsored article published by The Motley Fool. 
July 15, 2019

Khiron Provides Corporate Update on Commercial and Operational Activities

Khiron Life Sciences Corp. ("Khiron" or the "Company") (TSXV:KHRN, OTCQB:KHRNF, Frankfurt:A2JMZC), a vertically integrated cannabis leader with core operations in Latin America, is...
July 8, 2019

Khiron Leads Cannabis Education at XLIV International Course of Internal Medicine, Reaching Over 2,000 Medical Specialists in Mexico

Khiron Life Sciences Corp. ("Khiron" or the "Company") (TSXV:KHRN, OTCQB:KHRNF), a cannabis company with core operations in Latin America announced today its participation...
July 4, 2019

Khiron President: We’re Increasing Our Dominant Position in Latin America

Khiron President Chris Naprawa provided an update on the company’s recent activities and his thoughts on the Latin American cannabis...
July 2, 2019

Khiron Welcomes EU Trade Deal with Latin American Countries

Khiron Life Sciences Corp. ("Khiron" or the "Company") (TSXV:KHRN), (OTCQB:KHRNF), (Frankfurt: A2JMZC), a cannabis company with core operations in Latin America, applauds...
June 25, 2019

Khiron President Chris Naprawa to Participate in Grit Capital Virtual Investor Conference

Khiron Life Sciences Corp. ("Khiron" or the "Company") (TSXV: KHRN), (OTCQB: KHRNF), (Frankfurt: A2JMZC) announces today that Company president Chris Naprawa will be presenting...